Why the study?
Does EnSite NavX-guided ablation reduce recurrence of atrial flutter and fluoroscopy time compared to conventional fluoroscopy in patients with typical atrial flutter?
Does EnSite NavX-guided ablation reduce recurrence of atrial flutter and fluoroscopy time compared to conventional fluoroscopy in patients with typical atrial flutter?
EnSite NavX 3D mapping for cavotricuspid isthmus ablation significantly reduces fluoroscopy time and long-term atrial flutter recurrence compared to conventional fluoroscopy.
Answers are grounded in this paper and cite their sources.
Supports routine EnSite NavX use for typical AFL ablation to cut recurrences and radiation; extends RCT evidence favoring 3D mapping.
OBJECTIVE: The aim of this prospective, randomised study was to evaluate the efficacy, safety and long-term outcomes of the complete disappearance of local electrograms along the linear lesion using the EnSite NavX three-dimensional mapping system as compared with conventional fluoroscopy for ablation of typical atrial flutter (AFL). METHODS: Seventy-three patients with spontaneous AFL episodes were randomised to undergo fluoroscopy-guided (group I, n=35) or EnSite NavX-guided (group II, n=38) ablation. When bidirectional isthmus block was achieved, the catheter was navigated back along the ablation line to assess the presence of local potentials along the lesion line. RESULTS: Bidirectional isthmus block was achieved in all patients. Mean total fluoroscopy time was 19.8 +/- 4.1 min in group I and 9.1 +/- 3.5 min in group II (P<0.001); mean fluoroscopy time required for radiofrequency ablation was 6.9 +/- 1.4 min in group I and 0.6 +/- 0.3 min in group II (P<0.001). During a follow-up of 16 +/- 9 months, three patients in group I (10%) experienced recurrence of AFL as opposed to none in group II (P<0.005). CONCLUSIONS: NavX technology allows accurate re-navigation of the lesion line to assess the presence of local potentials during an ablation procedure for typical AFL. Electroanatomic activation mapping can accurately identify gaps in the linear radiofrequency lesion with no AFL recurrence compared with 20% of recurrences after a standard procedure.
No takes yet. Share an insight, caveat, or question.
Muto et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: